Sort
51,593 grants matching “hepatitis”
Immune correlates of acute HBV recovery with and without HIV
$616,491Chloe L Thio · Johns Hopkins University · R01 · FY2018 · AI
The Pathobiology of Hepatic Epithelia
$616,490Nicholas F. Larusso · Mayo Clinic Rochester · R01 · FY2009 · DK
Reverse-engineering precision liver cancer chemoprevention
$616,470Yujin Hoshida · Ut Southwestern Medical Center · R01 · FY2022 · CA
Pathways Towards Immune Tolerance To Coagulation Factors
$616,377Roland W. Herzog · Wistar Institute · P01 · FY2014 · HL
Identification and Regulation of RNA Modification by HIV infection and Methamphetamine
$616,347Tariq M Rana · University Of California, San Diego · R01 · FY2020 · DA
Peripheral Reservoir of HIV DNA in Monocytes Pivotal to Cognition in HIV
$616,298Victor Valcour · University Of California, San Francisco · R01 · FY2012 · NS
Monitoring Variation in Mixtures of Long RNAs with End-to-End RT Sequencing
$616,248Anna Marie Pyle · Yale University · R01 · FY2019 · HG
Blocking hepatocyte senescence as a novel therapeutic strategy for chronic liver diseases
$616,187Michael Oertel · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · DK
Blocking hepatocyte senescence as a novel therapeutic strategy for chronic liver diseases
$616,187Michael Oertel · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · DK
Identification and Regulation of RNA Modification by HIV infection and Methamphetamine
$616,135Tariq M Rana · University Of California, San Diego · R01 · FY2021 · DA
Quantitative Multimodal Imaging Biomarkers for Combined Locoregional and Immunotherapy of Liver Cancer
$616,121James S Duncan · Yale University · R01 · FY2022 · CA
Extended Storage of Tissues and Organs in Subzero Environments
$615,964Martin L Yarmush · Massachusetts General Hospital · R01 · FY2012 · EB
Identification and Regulation of RNA Modification by HIV infection and Methamphetamine
$615,921Tariq M Rana · University Of California, San Diego · R01 · FY2022 · DA
Immunogenetic Study of Infectious Diseases and Cancer
$615,901Francesco M Marincola · Clinical Center · Z01 · FY2007 · CL
DEVELOPING MULTI-ANTIGEN VACCINE FOR THE TREATMENT OF CHRONIC HBV
$615,763Valerian Nakaar · Carogen Corporation · R44 · FY2019 · DK
Models of AT Deficiency Using Human Hepatocytes
$615,644Ira J. Fox · Washington University · P01 · FY2021 · DK
Glycopathology of HCC: identification of the source cells of serum fucosylation
$615,632Anand S Mehta · Medical University Of South Carolina · U01 · FY2020 · CA
Expanding Medication Assisted Therapy in Ukraine (ExMAT)
$615,610Frederick Lewis Altice · Yale University · R01 · FY2021 · DA
Genomics and pharmacodynamics of statin-related rhabdomyolysis
$615,504Bruce M Psaty · University Of Washington · R01 · FY2013 · HL
Liver Cancer Control Among North American Chinese
$615,493Fred Hutchinson Cancer Research Center · R01 · FY2004 · CA
Behavioral Aspects of HIV/HCV/HBV risks in New Injectors
$615,319National Development &Res Institutes · R01 · FY2005 · DA
HIV/STD Infection in an Urban High Risk Population
$615,310Larry Allen Nuttbrock · National Development And Research Institutes, Inc. · R01 · FY2006 · DA
Formation of the Drosophila salivary gland
$615,308Deborah J. Andrew · Johns Hopkins University · R01 · FY2025 · DE
Small GTP Binding Proteins in Gastrointestinal Mucosa
$615,274James R Goldenring · Vanderbilt University Medical Center · R01 · FY2022 · DK
Small GTP Binding Proteins in Gastrointestinal Mucosa
$615,274James R Goldenring · Vanderbilt University Medical Center · R01 · FY2023 · DK